Operating Income: The income after operating expenses.
Liminatus Pharma Inc. (LIMN) had Operating Income of $-1.38M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.41M |
|
-- |
|
-- |
|
$1.38M |
|
|
Operating Income |
$-1.38M |
$-0.03M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.41M |
|
$-1.38M |
|
$-1.38M |
|
0.97M |
|
0.97M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$3.39M |
|
$0.01M |
|
$0.01M |
|
$3.40M |
|
$3.04M |
|
-- |
|
$0.06M |
|
$3.10M |
|
$0.30M |
|
$0.30M |
|
$0.30M |
|
1.12M |
|
| Cash Flow Statement Financials | |
$-2.99M |
|
-- |
|
$5.66M |
|
$0.34M |
|
$3.02M |
|
$2.68M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
-- |
|
4.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-468.14% |
|
-468.13% |
|
-41.34% |
|
-468.13% |
|
$0.27 |
|
$-3.08 |
|
$-3.08 |
|